• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Therapy
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global breast cancer therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global breast cancer therapeutics market 2017 – 2021 ($ million)
o 4.2 Disease type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Disease type Segment 2017 – 2021 ($ million)
o 4.3 Therapy Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Therapy Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Disease Type
o 6.1 Market segments
o Exhibit 30: Chart on Disease Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Disease Type – Market share 2022-2027 (%)
o 6.2 Comparison by Disease Type
o Exhibit 32: Chart on Comparison by Disease Type
o Exhibit 33: Data Table on Comparison by Disease Type
o 6.3 Invasive breast cancers – Market size and forecast 2022-2027
o Exhibit 34: Chart on Invasive breast cancers – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Invasive breast cancers – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Invasive breast cancers – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Invasive breast cancers – Year-over-year growth 2022-2027 (%)
o 6.4 Ductal carcinoma in situ – Market size and forecast 2022-2027
o Exhibit 38: Chart on Ductal carcinoma in situ – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Ductal carcinoma in situ – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Ductal carcinoma in situ – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Ductal carcinoma in situ – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Disease Type
o Exhibit 42: Market opportunity by Disease Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Disease Type ($ million)
• 7 Market Segmentation by Therapy
o 7.1 Market segments
o Exhibit 44: Chart on Therapy – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Therapy – Market share 2022-2027 (%)
o 7.2 Comparison by Therapy
o Exhibit 46: Chart on Comparison by Therapy
o Exhibit 47: Data Table on Comparison by Therapy
o 7.3 Targeted therapy – Market size and forecast 2022-2027
o Exhibit 48: Chart on Targeted therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Targeted therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Targeted therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Targeted therapy – Year-over-year growth 2022-2027 (%)
o 7.4 Hormonal therapy – Market size and forecast 2022-2027
o Exhibit 52: Chart on Hormonal therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Hormonal therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Hormonal therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Hormonal therapy – Year-over-year growth 2022-2027 (%)
o 7.5 Chemotherapy – Market size and forecast 2022-2027
o Exhibit 56: Chart on Chemotherapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Chemotherapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Chemotherapy – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Chemotherapy – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Therapy
o Exhibit 60: Market opportunity by Therapy ($ million)
o Exhibit 61: Data Table on Market opportunity by Therapy ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 91: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 95: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. – Overview
o Exhibit 112: AbbVie Inc. – Product / Service
o Exhibit 113: AbbVie Inc. – Key news
o Exhibit 114: AbbVie Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 115: Amgen Inc. – Overview
o Exhibit 116: Amgen Inc. – Product / Service
o Exhibit 117: Amgen Inc. – Key offerings
o 12.5 AstraZeneca
o Exhibit 118: AstraZeneca – Overview
o Exhibit 119: AstraZeneca – Product / Service
o Exhibit 120: AstraZeneca – Key news
o Exhibit 121: AstraZeneca – Key offerings
o 12.6 Bristol Myers Squibb
o Exhibit 122: Bristol Myers Squibb – Overview
o Exhibit 123: Bristol Myers Squibb – Product / Service
o Exhibit 124: Bristol Myers Squibb – Key news
o Exhibit 125: Bristol Myers Squibb – Key offerings
o 12.7 Clovis Oncology
o Exhibit 126: Clovis Oncology – Overview
o Exhibit 127: Clovis Oncology – Business segments
o Exhibit 128: Clovis Oncology – Key offerings
o Exhibit 129: Clovis Oncology – Segment focus
o 12.8 Daiichi Sankyo Co. Ltd.
o Exhibit 130: Daiichi Sankyo Co. Ltd. – Overview
o Exhibit 131: Daiichi Sankyo Co. Ltd. – Product / Service
o Exhibit 132: Daiichi Sankyo Co. Ltd. – Key news
o Exhibit 133: Daiichi Sankyo Co. Ltd. – Key offerings
o 12.9 Eli Lilly and Co.
o Exhibit 134: Eli Lilly and Co. – Overview
o Exhibit 135: Eli Lilly and Co. – Product / Service
o Exhibit 136: Eli Lilly and Co. – Key news
o Exhibit 137: Eli Lilly and Co. – Key offerings
o 12.10 Exelixis Inc.
o Exhibit 138: Exelixis Inc. – Overview
o Exhibit 139: Exelixis Inc. – Product / Service
o Exhibit 140: Exelixis Inc. – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 141: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 142: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 143: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 144: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 145: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 GlaxoSmithKline Plc
o Exhibit 146: GlaxoSmithKline Plc – Overview
o Exhibit 147: GlaxoSmithKline Plc – Business segments
o Exhibit 148: GlaxoSmithKline Plc – Key news
o Exhibit 149: GlaxoSmithKline Plc – Key offerings
o Exhibit 150: GlaxoSmithKline Plc – Segment focus
o 12.13 Merck and Co. Inc.
o Exhibit 151: Merck and Co. Inc. – Overview
o Exhibit 152: Merck and Co. Inc. – Business segments
o Exhibit 153: Merck and Co. Inc. – Key news
o Exhibit 154: Merck and Co. Inc. – Key offerings
o Exhibit 155: Merck and Co. Inc. – Segment focus
o 12.14 NanoString Technologies Inc.
o Exhibit 156: NanoString Technologies Inc. – Overview
o Exhibit 157: NanoString Technologies Inc. – Product / Service
o Exhibit 158: NanoString Technologies Inc. – Key offerings
o 12.15 Novartis AG
o Exhibit 159: Novartis AG – Overview
o Exhibit 160: Novartis AG – Business segments
o Exhibit 161: Novartis AG – Key offerings
o Exhibit 162: Novartis AG – Segment focus
o 12.16 Perkin Elmer Inc.
o Exhibit 163: Perkin Elmer Inc. – Overview
o Exhibit 164: Perkin Elmer Inc. – Business segments
o Exhibit 165: Perkin Elmer Inc. – Key news
o Exhibit 166: Perkin Elmer Inc. – Key offerings
o Exhibit 167: Perkin Elmer Inc. – Segment focus
o 12.17 Pfizer Inc.
o Exhibit 168: Pfizer Inc. – Overview
o Exhibit 169: Pfizer Inc. – Product / Service
o Exhibit 170: Pfizer Inc. – Key news
o Exhibit 171: Pfizer Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 172: Inclusions checklist
o Exhibit 173: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 174: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 175: Research methodology
o Exhibit 176: Validation techniques employed for market sizing
o Exhibit 177: Information sources
o 13.5 List of abbreviations
o Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global breast cancer therapeutics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Disease type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Therapy Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Disease Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Disease Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Disease Type
Exhibits33: Data Table on Comparison by Disease Type
Exhibits34: Chart on Invasive breast cancers – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Invasive breast cancers – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Invasive breast cancers – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Invasive breast cancers – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Ductal carcinoma in situ – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Ductal carcinoma in situ – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Ductal carcinoma in situ – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Ductal carcinoma in situ – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Disease Type ($ million)
Exhibits43: Data Table on Market opportunity by Disease Type ($ million)
Exhibits44: Chart on Therapy – Market share 2022-2027 (%)
Exhibits45: Data Table on Therapy – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Therapy
Exhibits47: Data Table on Comparison by Therapy
Exhibits48: Chart on Targeted therapy – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Targeted therapy – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Targeted therapy – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Targeted therapy – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Hormonal therapy – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Hormonal therapy – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Hormonal therapy – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hormonal therapy – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Chemotherapy – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Chemotherapy – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Chemotherapy – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Chemotherapy – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Therapy ($ million)
Exhibits61: Data Table on Market opportunity by Therapy ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. – Overview
Exhibits112: AbbVie Inc. – Product / Service
Exhibits113: AbbVie Inc. – Key news
Exhibits114: AbbVie Inc. – Key offerings
Exhibits115: Amgen Inc. – Overview
Exhibits116: Amgen Inc. – Product / Service
Exhibits117: Amgen Inc. – Key offerings
Exhibits118: AstraZeneca – Overview
Exhibits119: AstraZeneca – Product / Service
Exhibits120: AstraZeneca – Key news
Exhibits121: AstraZeneca – Key offerings
Exhibits122: Bristol Myers Squibb – Overview
Exhibits123: Bristol Myers Squibb – Product / Service
Exhibits124: Bristol Myers Squibb – Key news
Exhibits125: Bristol Myers Squibb – Key offerings
Exhibits126: Clovis Oncology – Overview
Exhibits127: Clovis Oncology – Business segments
Exhibits128: Clovis Oncology – Key offerings
Exhibits129: Clovis Oncology – Segment focus
Exhibits130: Daiichi Sankyo Co. Ltd. – Overview
Exhibits131: Daiichi Sankyo Co. Ltd. – Product / Service
Exhibits132: Daiichi Sankyo Co. Ltd. – Key news
Exhibits133: Daiichi Sankyo Co. Ltd. – Key offerings
Exhibits134: Eli Lilly and Co. – Overview
Exhibits135: Eli Lilly and Co. – Product / Service
Exhibits136: Eli Lilly and Co. – Key news
Exhibits137: Eli Lilly and Co. – Key offerings
Exhibits138: Exelixis Inc. – Overview
Exhibits139: Exelixis Inc. – Product / Service
Exhibits140: Exelixis Inc. – Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. – Overview
Exhibits142: F. Hoffmann La Roche Ltd. – Business segments
Exhibits143: F. Hoffmann La Roche Ltd. – Key news
Exhibits144: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits146: GlaxoSmithKline Plc – Overview
Exhibits147: GlaxoSmithKline Plc – Business segments
Exhibits148: GlaxoSmithKline Plc – Key news
Exhibits149: GlaxoSmithKline Plc – Key offerings
Exhibits150: GlaxoSmithKline Plc – Segment focus
Exhibits151: Merck and Co. Inc. – Overview
Exhibits152: Merck and Co. Inc. – Business segments
Exhibits153: Merck and Co. Inc. – Key news
Exhibits154: Merck and Co. Inc. – Key offerings
Exhibits155: Merck and Co. Inc. – Segment focus
Exhibits156: NanoString Technologies Inc. – Overview
Exhibits157: NanoString Technologies Inc. – Product / Service
Exhibits158: NanoString Technologies Inc. – Key offerings
Exhibits159: Novartis AG – Overview
Exhibits160: Novartis AG – Business segments
Exhibits161: Novartis AG – Key offerings
Exhibits162: Novartis AG – Segment focus
Exhibits163: Perkin Elmer Inc. – Overview
Exhibits164: Perkin Elmer Inc. – Business segments
Exhibits165: Perkin Elmer Inc. – Key news
Exhibits166: Perkin Elmer Inc. – Key offerings
Exhibits167: Perkin Elmer Inc. – Segment focus
Exhibits168: Pfizer Inc. – Overview
Exhibits169: Pfizer Inc. – Product / Service
Exhibits170: Pfizer Inc. – Key news
Exhibits171: Pfizer Inc. – Key offerings
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations